545 related articles for article (PubMed ID: 28057871)
1. Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients.
Zittema D; van den Brand JA; Bakker SJ; Wetzels JF; Gansevoort RT
Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i146-i153. PubMed ID: 28057871
[TBL] [Abstract][Full Text] [Related]
2. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy.
Peters HP; van den Brand JA; Wetzels JF
Neth J Med; 2009 Feb; 67(2):54-61. PubMed ID: 19299847
[TBL] [Abstract][Full Text] [Related]
4. Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy.
Park GY; Yu CH; Kim JS; Kang YJ; Kwon O; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
Korean J Intern Med; 2015 May; 30(3):345-53. PubMed ID: 25995665
[TBL] [Abstract][Full Text] [Related]
5. Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33).
Boertien WE; Riphagen IJ; Drion I; Alkhalaf A; Bakker SJ; Groenier KH; Struck J; de Jong PE; Bilo HJ; Kleefstra N; Gansevoort RT
Diabetologia; 2013 Aug; 56(8):1680-8. PubMed ID: 23624546
[TBL] [Abstract][Full Text] [Related]
6. Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD).
Nakajima A; Lu Y; Kawano H; Horie S; Muto S
Clin Exp Nephrol; 2015 Dec; 19(6):1199-205. PubMed ID: 25715868
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of NGAL staining in patients with IgA nephropathy.
Yavas H; Sahin OZ; Ersoy R; Taşlı F; Gibyeli Genek D; Uzum A; Cirit M
Ren Fail; 2013; 35(4):472-6. PubMed ID: 23413884
[TBL] [Abstract][Full Text] [Related]
8. Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CRISP cohort.
Boertien WE; Meijer E; Li J; Bost JE; Struck J; Flessner MF; Gansevoort RT; Torres VE;
Am J Kidney Dis; 2013 Mar; 61(3):420-9. PubMed ID: 23089511
[TBL] [Abstract][Full Text] [Related]
9. Urinary excretion of β2-microglobulin as a prognostic marker in immunoglobulin A nephropathy.
Shin JR; Kim SM; Yoo JS; Park JY; Kim SK; Cho JH; Jeong KH; Lee TW; Ihm CG
Korean J Intern Med; 2014 May; 29(3):334-40. PubMed ID: 24851068
[TBL] [Abstract][Full Text] [Related]
10. Uric Acid as a Predictor of Immunoglobulin A Nephropathy Progression: A Cohort Study of 1965 Cases.
Zhu B; Yu DR; Lv JC; Lin Y; Li Q; Yin JZ; Du YY; Tang XL; Mao LC; Li QF; Sun Y; Liu L; Li XF; Fei D; Wei XY; Zhu CF; Cheng XX; Chen HY; Wang YJ
Am J Nephrol; 2018; 48(2):127-136. PubMed ID: 30110674
[TBL] [Abstract][Full Text] [Related]
11. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy.
Liu D; You J; Liu Y; Tang X; Tan X; Xia M; Wu L; Chen G; He L; Zhu X; Liu H
Int Immunopharmacol; 2019 Jan; 66():13-18. PubMed ID: 30415190
[TBL] [Abstract][Full Text] [Related]
12. Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes.
Velho G; Ragot S; El Boustany R; Saulnier PJ; Fraty M; Mohammedi K; Fumeron F; Potier L; Marre M; Hadjadj S; Roussel R
Cardiovasc Diabetol; 2018 Aug; 17(1):110. PubMed ID: 30071874
[TBL] [Abstract][Full Text] [Related]
13. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
Rhee H; Shin N; Shin MJ; Yang BY; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY
Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Copeptin in Chronic Kidney Disease: From General Population to End-Stage Renal Disease.
Golembiewska E; Machowska A; Stenvinkel P; Lindholm B
Curr Protein Pept Sci; 2017; 18(12):1232-1243. PubMed ID: 28714397
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria.
Chen D; Liu J; Duan S; Chen P; Tang L; Zhang L; Feng Z; Cai G; Wu J; Chen X
Kidney Blood Press Res; 2018; 43(2):318-328. PubMed ID: 29529608
[TBL] [Abstract][Full Text] [Related]
16. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
Yang X; Ou J; Zhang H; Xu X; Zhu L; Li Q; Li J; Xie D; Sun J; Zha Y; Li Y; Tian J; Liu Y; Hou FF
Am J Kidney Dis; 2020 Mar; 75(3):384-393. PubMed ID: 31606236
[TBL] [Abstract][Full Text] [Related]
17. Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy.
Sonoda Y; Gohda T; Suzuki Y; Omote K; Ishizaka M; Matsuoka J; Tomino Y
PLoS One; 2015; 10(4):e0122212. PubMed ID: 25860248
[TBL] [Abstract][Full Text] [Related]
18. Copeptin is associated with kidney length, renal function, and prevalence of simple cysts in a population-based study.
Ponte B; Pruijm M; Ackermann D; Vuistiner P; Guessous I; Ehret G; Alwan H; Youhanna S; Paccaud F; Mohaupt M; Péchère-Bertschi A; Vogt B; Burnier M; Martin PY; Devuyst O; Bochud M
J Am Soc Nephrol; 2015 Jun; 26(6):1415-25. PubMed ID: 25270071
[TBL] [Abstract][Full Text] [Related]
19. Urine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment.
Zittema D; Casteleijn NF; Bakker SJ; Boesten LS; Duit AA; Franssen CF; Gaillard CA; Gansevoort RT
PLoS One; 2017; 12(1):e0169263. PubMed ID: 28081165
[TBL] [Abstract][Full Text] [Related]
20. Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria.
Velho G; Bouby N; Hadjadj S; Matallah N; Mohammedi K; Fumeron F; Potier L; Bellili-Munoz N; Taveau C; Alhenc-Gelas F; Bankir L; Marre M; Roussel R
Diabetes Care; 2013 Nov; 36(11):3639-45. PubMed ID: 23863910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
